Ocriplasmin for Treatment of Vitreomacular Traction: An Update.

Ophthalmol Ther · 2016 · PMC5125123 · PMID 27619226

Europe PMC DOI

hedged sentence

0.1630

closest p · 3.3× alpha

0.1630

boldest claim

The sentences

did not reach statistical significancep = 0.163not close (p > 0.1)

While FTMH closure occurred at a higher rate in the ocriplasmin group, this did not reach statistical significance (30% versus 15.4%, p = 0.163) [ 10 ].

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.